Skip to main content
Premium Trial:

Request an Annual Quote

Illumina TruSight RNA Pan-Cancer Panel

Illumina has launched the TruSight RNA Pan-Cancer Panel for comprehensive analysis of the cancer transcriptome. The panel targets 1,385 cancer-related transcripts and genes known to be involved in gene fusions, and provides gene expression information, variant calling, and fusion detection with known and novel gene fusion partners. The kit is designed for use with a wide range of sample types, and can be used with as little as 10 ng of total RNA input, or 20 ng from formalin-fixed, paraffin-embedded tissue, and can be used with as little. The panel is compatible with Illumina's NextSeq 500 and MiSeq sequencing systems.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.